Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 1298198, 10 pages
http://dx.doi.org/10.1155/2016/1298198
Research Article

G-1639A but Not C1173T VKORC1 Gene Polymorphism Is Related to Ischemic Stroke and Its Various Risk Factors in Ukrainian Population

1Department of Physiology, Pathophysiology and Medical Biology, Sumy State University, Sumy 40007, Ukraine
2Scientific Laboratory of Molecular Genetic Research, Sumy State University, Sumy 40007, Ukraine

Received 28 May 2016; Revised 25 July 2016; Accepted 17 August 2016

Academic Editor: Emin Karaca

Copyright © 2016 Yevhen I. Dubovyk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Oldenburg, M. Marinova, C. Müller-Reible, and M. Watzka, “The vitamin K Cycle,” Vitamins and Hormones, vol. 78, pp. 35–62, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Caspers, K. J. Czogalla, K. Liphardt et al., “Two enzymes catalyze vitamin K 2,3-epoxide reductase activity in mouse: VKORC1 is highly expressed in exocrine tissues while VKORC1L1 is highly expressed in brain,” Thrombosis Research, vol. 135, no. 5, pp. 977–983, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. M. S. El Asmar, J. J. Naoum, and E. J. Arbid, “Vitamin K dependent proteins and the role of vitamin K2 in the modulation of vascular calcification: a review,” Oman Medical Journal, vol. 29, no. 3, pp. 172–177, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. C. S. B. Viegas, M. S. Rafael, J. L. Enriquez et al., “Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 35, no. 2, pp. 399–408, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Laurance, C. A. Lemarié, and M. D. Blostein, “Growth arrest-specific gene 6 (gas6) and vascular hemostasis,” Advances in Nutrition, vol. 3, no. 2, pp. 196–203, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Li, C.-Y. Chang, D.-Y. Jin, P.-J. Lin, A. Khvorova, and D. W. Stafford, “Identification of the gene for vitamin K epoxide reductase,” Nature, vol. 427, no. 6974, pp. 541–544, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Rost, A. Fregin, V. Ivaskevicius et al., “Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2,” Nature, vol. 427, no. 6974, pp. 537–541, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Teichert, L. E. Visser, R. H. N. van Schaik et al., “Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) polymorphism and aortic calcification,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 4, pp. 771–776, 2008. View at Publisher · View at Google Scholar
  9. M. N. Watzka, A. Nebel, E. Mokhtari et al., “Functional promoter polymorphism in the VKORC1 gene is no major genetic determinant for coronary heart disease in Northern Germans,” Thrombosis and Haemostasis, vol. 97, no. 6, pp. 998–1002, 2007. View at Google Scholar
  10. D. M. Smadja, M.-A. Loriot, L. A. Hindorff, L. Mellottee, P. Gaussem, and J. Emmerich, “No clear link between VKORC1 genetic polymorphism and the risk of venous thrombosis or peripheral arterial disease,” Thrombosis and Haemostasis, vol. 99, no. 5, pp. 970–972, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Fodor, C. Bondor, A. Albu, R. Popp, I. V. Pop, and L. Poanta, “Relationship between VKORC1 single nucleotide polymorphism 1173C>T, bone mineral density & carotid intima-media thickness,” Indian Journal of Medical Research, vol. 137, no. 4, pp. 734–741, 2013. View at Google Scholar · View at Scopus
  12. A. Tavridou, I. Petridis, M. Vasileiadis et al., “Association of VKORC1 −1639G>A polymorphism with carotid intima-media thickness in type 2 diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 94, no. 2, pp. 236–241, 2011. View at Google Scholar
  13. Y. Wang, W. Zhang, Y. Zhang et al., “VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection),” Circulation, vol. 113, no. 12, pp. 1615–1621, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Zhang, L. Yang, Q. Feng, Y. Fan, H. Zheng, and Y. He, “Association between VKORC1 gene polymorphisms and ischemic cerebrovascular disease in Chinese Han population,” Journal of Molecular Neuroscience, vol. 53, no. 2, pp. 166–170, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Du, Z. Zhang, Y. Ge, J. Zhen, J. Leng, and J. Wang, “VKORC1 and CD-14 genetic polymorphisms associate with susceptibility to cardiovascular and cerebrovascular diseases,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 11, pp. 20444–20453, 2015. View at Google Scholar · View at Scopus
  16. M.-L. Arnold, C. Lichy, I. Werner, A. Radbruch, S. Wagner, and C. Grond-Ginsbach, “Single nucleotide polymorphisms in the VKORC1 gene and the risk of stroke in the Southern German population,” Thrombosis and Haemostasis, vol. 100, no. 4, pp. 614–617, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Ragia, S. Marousi, J. Ellul, V. G. Manolopoulos, and A. Tavridou, “Association of functional VKORC1 promoter polymorphism with occurrence and clinical aspects of ischemic stroke in a Greek population,” Disease Markers, vol. 35, no. 6, pp. 641–646, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. H.-Y. Shyu, C.-S. Fong, Y.-P. Fu et al., “Genotype polymorphisms of GGCX, NQO1, and VKORC1 genes associated with risk susceptibility in patients with large-artery atherosclerotic stroke,” Clinica Chimica Acta, vol. 411, no. 11-12, pp. 840–845, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. L. A. Hindorff, S. R. Heckbert, N. Smith, K. D. Marciante, and B. M. Psaty, “Common VKORC1 variants are not associated with arterial or venous thrombosis,” Journal of Thrombosis and Haemostasis, vol. 5, no. 10, pp. 2025–2027, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Lemmens, S. Abboud, L. Vanhees, A. Goris, and V. Thijs, “Lack of association between variants in the VKORC1 gene and cerebrovascular or coronary heart disease,” Journal of Thrombosis and Haemostasis, vol. 6, no. 12, pp. 2220–2223, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. H. P. Adams and B. H. Bendixen, “Classification of subtype of acute ischemic stroke definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment,” Stroke, vol. 24, no. 1, pp. 35–41, 1993. View at Publisher · View at Google Scholar · View at Scopus
  22. G. D'Andrea, R. L. D'Ambrosio, P. Di Perna et al., “A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin,” Blood, vol. 105, no. 2, pp. 645–649, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Wang, H. Chen, K. M. Momary et al., “Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement,” Blood, vol. 112, no. 4, pp. 1013–1021, 2008. View at Publisher · View at Google Scholar
  24. H.-Y. Yuan, J.-J. Chen, M. T. M. Lee et al., “A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity,” Human Molecular Genetics, vol. 14, no. 13, pp. 1745–1751, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Y. Garbuzova, D. A. Stroy, V. E. Dosenko et al., “Association of allelic polymorphisms of genes matrix Gla-protein system with ischemic atherothrombotic stroke,” Fiziolohichnyĭ Zhurnal, vol. 61, no. 1, pp. 19–27, 2015. View at Google Scholar · View at Scopus
  26. Y. Li, J. Zhu, and J. Q. Ding, “VKORC1 rs2359612 and rs9923231 polymorphisms correlate with high risks of cardiovascular and cerebrovascular diseases,” Genetics and Molecular Research, vol. 14, no. 4, pp. 14731–14744, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. S. L. Booth and A. A. Rajabi, “Determinants of vitamin K status in humans,” Vitamins and Hormones, vol. 78, pp. 1–22, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. J. C. McCann and B. N. Ames, “Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging?” The American Journal of Clinical Nutrition, vol. 90, no. 4, pp. 889–907, 2009. View at Publisher · View at Google Scholar · View at Scopus